Dexamethasone vs Methylprednisolone for Asthma

(PATCH Trial)

This trial aims to determine the most effective steroid treatment for children hospitalized with severe asthma attacks. It compares three different steroid dosing schedules to identify which one reduces the need for additional medication and improves the patient's quality of life. Children hospitalized in the intensive care unit for critical asthma are suitable candidates for this study. As a Phase 2 trial, it measures the treatment's effectiveness in an initial, smaller group, providing an opportunity to contribute to important research.

The trial information does not specify if you need to stop your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that both dexamethasone and methylprednisolone are generally safe and effective for treating asthma in children. Studies have found dexamethasone to be safe and effective, with various doses yielding positive results for kids with asthma. Specifically, one study found that children using dexamethasone for severe asthma experienced good safety outcomes, making it a reliable choice.

Regarding methylprednisolone, research also supports its safety for asthma treatment. Studies comparing it to other anti-inflammatory medicines found it to be equally safe and effective. The FDA has approved methylprednisolone for treating asthma, further supporting its safety.

Researchers are excited about these treatments for asthma because they offer different dosing schedules that could improve patient convenience and outcomes. Dexamethasone is being tested in two dosing regimens: once daily and every 6 hours, both for just two days, which could make it more convenient compared to the traditional longer courses of steroids like prednisone. Methylprednisolone, on the other hand, is being administered every 6 hours for five days, offering another option for those who may benefit from a more sustained regimen. These variations in dosing could provide more tailored treatment options, potentially leading to better management of asthma symptoms with fewer side effects.

This trial will compare different dosing regimens of Dexamethasone and Methylprednisolone for managing asthma flare-ups. Research has shown that Dexamethasone effectively manages asthma flare-ups, with studies indicating that a single dose can work as well as taking other steroids like prednisolone over a longer period. In this trial, participants may receive Dexamethasone once daily or every 6 hours. Methylprednisolone, another treatment option in this trial, has significantly improved asthma symptoms, especially in severe cases where higher doses are often used. However, some studies found no clear advantage of very high doses over standard ones. Both treatments are strongly supported by evidence for effectively reducing asthma symptoms.¹⁶⁷⁸⁹